Lindsey Jones, PhD
Program: Biomedical Sciences
Research interests: Patient-dervied models of glioma; mechanisms of glioma hypermutation
Dr. Jones graduated in 2018 and is currently at Color Genomics.
2013: BS, Nebraska Wesleyan University
2018: PhD, UCSF
2018: Director of Content, Gene Friend Way (startup)
2016-Present: Contributor, UCSF Synapse
2017: Staff Writer, Biotech Connection
2017: Outstanding Poster Presentation, Society for Neuro-Oncology Annual Meeting
Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.
Hayes J, Yu Y, Jalbert LE, Mazor T, Jones LE, Wood MD, Walsh KM, Bengtsson H, Hong C, Oberndorfer S, Roetzer T, Smirnov IV, Clarke JL, Aghi MK, Chang SM, Nelson SJ, Woehrer A, Phillips JJ, Solomon DA, Costello JF
Neuro Oncol. 2018 Apr 9;20(5):632-641. doi: 10.1093/neuonc/nox205.
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
Mancini A, Xavier-Magalhães A, Woods WS, Nguyen KT, Amen AM, Hayes JL, Fellmann C, Gapinske M, McKinney AM, Hong C, Jones LE, Walsh KM, Bell RJA1, Doudna JA, Costa BM, Song JS, Perez-Pinera P, Costello JF
Cancer Cell. 2018 Sept 10;34(3):513-528.e8. doi: 0.1016/j.ccell.2018.08.003.
Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper R
Cancer Res. 2018 Jun 1;78(11):2966-2977.e8. doi: 10.1158/0008-5472.CAN-17-2269. Epub 2018 Mar 15.
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO
Cancer Res. 2016 Nov 15;76(22):6680-6689. doi: 0.1158/0008-5472.CAN-16-0696. Epub 2016 Oct 6.